Acuta Capital Partners’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
2023
Q3
$834K Hold
2023
Q2
$1.26M Sell
2023
Q1
$986K Sell
2022
Q4
$4.02M Buy
2022
Q3
$2.53M Sell
2022
Q2
$2.69M Sell
2022
Q1
$3.75M Buy
2021
Q4
$1.43M Sell
2021
Q3
$2.54M Sell
2021
Q2
$3.07M Sell
2021
Q1
$8.01M Buy
2018
Q1
Sell
2017
Q4
$2.28M Buy
2017
Q3
Sell
2017
Q2
$2.44M Sell
2017
Q1
$5.96M Sell
2016
Q4
$10.1M Buy